Zdrowie i gospodarka · 17/09/2018

FDA Requests Public Comment on Proposed Collection of Information for Evaluating Bulk Drug Substances

The Food and Drug Administration is seeking public input on a proposed collection of information to support the establishment of a list of bulk drug substances under the FD&C Act, as part of its research on compounded drug products containing certain bulk drug substances.